Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8% GOLD 4170.10 +1.5% SILVER 57.16 +2.3% COPPER 6.56 −1.5% OIL 97.97 +3.0% PALLADIUM 1136.00 +3.6% LUN 32.91 +0.6% DLP 0.290 −3.3% VCV 0.065 −13.3% GG 2.89 +1.4% NBLC 0.015 +0.0% SF 0.300 −4.8% ATY 0.215 +2.4% GHL 0.060 −7.7% STND 0.060 −7.7% B 0.550 −3.5% HBM 34.33 −0.5% NTR 98.77 −0.7% SGZ 0.035 +0.0% MKA 0.670 +0.0% LXM 0.175 −18.6% CLCH 1.08 −1.8%
Financings

Restart Life Closes Over-Subscribed Second Tranche Financing

By The Northwire Desk — AI Analysis Dec 18, 2025 · 08:01 HEAL · 0.11 Restart Life Sciences Corp.
HEAL · Price

Executive Summary

  • Restart Life Sciences Corp. closed the oversubscribed second tranche of its non‑brokered private placement, raising CDN $630,000 and bringing total proceeds to CDN $1.13 million.
  • 6,300,000 units were issued at CDN $0.10 per unit; each unit includes one common share and one transferable warrant.
  • Proceeds will be used for health‑food trials, potential acquisitions, and general working capital.

Key Details

  • Total gross proceeds: CDN $1,130,000 (CDN $630,000 from the second tranche).
  • Units issued in second tranche: 6,300,000 units at CDN $0.10 per unit.
  • Unit composition: 1 common share + 1 transferable common share purchase warrant (exercise price CDN $0.10, one‑year term).
  • Finder warrants: 132,000 non‑transferable finder warrants issued to eligible finders; each grants the right to purchase one common share at CDN $0.10 for one year.
  • Hold period: All securities subject to a four‑month‑plus‑one‑day hold period expiring April 18, 2026.
  • Use of proceeds: Health food trials, potential acquisitions, and general working capital.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from Restart Life Sciences Corp.

Jun 18, 2026 · 06:01

Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods

Production / Operations Jun 10, 2026 · 08:01

Restart Life Subsidiary Holy Crap Foods Marks New International Expansion Milestone with Bahamas On-Demand App Launch

Production / Operations Jun 03, 2026 · 06:01

Restart Life Sciences Taps CFO to Steer Holy Crap Foods' North American Expansion and Omnichannel Push

M&A / Property May 21, 2026 · 06:01

Restart Life Closes Financing as Revenue Growth Fails to Halt Stock Erosion

Financings May 15, 2026 · 16:00

Restart Life Sciences Advances New Product Relaunch Utilizing Acquired Intellectual Property Portfolio

Production / Operations May 13, 2026 · 06:01

Restart Life Sciences Expands U.S. Footprint via Amazon Logistics Amidst Modest Revenue Growth and Capital Dilution

Other